Sufentanil (Orexo Ab)

舒芬太尼 (Orexo Ab)

Report date: 2024/07/31 20:00:31

Base Information

Drug NameSufentanil (Orexo Ab)
Drug Alias NameSufentanilOX-27
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMu opioid receptor agonistsδ-opioid receptor agonistsKappa opioid receptor agonists
TargetsMu opioid receptorδ-opioid receptorKappa opioid receptor
Therapy Area/IndicationsCancer Pain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesOrexo Ab (Pulb)
China Registration ClassN/A

Develop Information

Active CompaniesOrexo Ab (Pulb)
Inactive CompaniesN/A
Active IndicationsCancer Pain
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A